Pub Date : 2015-03-29DOI: 10.4172/2167-0420.1000229
Rana Sc, L. Chou, Tim Wang, Harris Ahs, S. Girod
Objective: Several female sub-populations of the healthcare industry, including radiologists, radiology technicians, and orthopedic surgeons, display an increased prevalence of breast cancer. Female plastic surgeons have a similar exposure to possible risk factors such as radiation exposure, late parturition, and overnight shifts. Therefore, this study aimed to evaluate the risk of breast cancer and overall cancer in female plastic surgeons. Methods: A two-page survey designed to collect data on respondent demographics, cancer incidence and exposure to social and occupational risk factors as identified in the current literature was mailed to 612 currently practicing female plastic surgeons identified by the American Society of Plastic Surgeons (ASPS). Prevalence rates for breast cancer and cancer in general were calculated. Only melanoma and internal cancers that were diagnosed within 15 years of the survey date were included, enabling us to compare the results with data from the National Institute’s Surveillance Epidemiology and End Results (SEER 11) Program. Standardized prevalence ratios (SPR), confidence intervals, and exact p-values were calculated. Results: Fourteen of the 352 respondents had been diagnosed with cancer, including three breast cancer cases, within 15 years preceeding the survey. These numbers are not signficantly lower than the expected prediction of 16 cancer and six breast cancer cases, based on the sex and race-specific prevalences in the general U.S. population. SPRs were 0.89 [95%CI: 0.49 to 1.5] for all cancers and 0.54 [95%CI: 0.11, 1.57] for breast cancer. Conclusion: Despite similarities to subpopulations with increased breast and overall cancer prevalence, the subpopulation of female plastic surgeons had no evdience of excess cancers compared to age and race-adjusted women in the general US population.
{"title":"Prevalence of Cancer in Female Plastic Surgeons in the United States","authors":"Rana Sc, L. Chou, Tim Wang, Harris Ahs, S. Girod","doi":"10.4172/2167-0420.1000229","DOIUrl":"https://doi.org/10.4172/2167-0420.1000229","url":null,"abstract":"Objective: Several female sub-populations of the healthcare industry, including radiologists, radiology technicians, and orthopedic surgeons, display an increased prevalence of breast cancer. Female plastic surgeons have a similar exposure to possible risk factors such as radiation exposure, late parturition, and overnight shifts. Therefore, this study aimed to evaluate the risk of breast cancer and overall cancer in female plastic surgeons. \u0000Methods: A two-page survey designed to collect data on respondent demographics, cancer incidence and exposure to social and occupational risk factors as identified in the current literature was mailed to 612 currently practicing female plastic surgeons identified by the American Society of Plastic Surgeons (ASPS). Prevalence rates for breast cancer and cancer in general were calculated. Only melanoma and internal cancers that were diagnosed within 15 years of the survey date were included, enabling us to compare the results with data from the National Institute’s Surveillance Epidemiology and End Results (SEER 11) Program. Standardized prevalence ratios (SPR), confidence intervals, and exact p-values were calculated. \u0000Results: Fourteen of the 352 respondents had been diagnosed with cancer, including three breast cancer cases, within 15 years preceeding the survey. These numbers are not signficantly lower than the expected prediction of 16 cancer and six breast cancer cases, based on the sex and race-specific prevalences in the general U.S. population. SPRs were 0.89 [95%CI: 0.49 to 1.5] for all cancers and 0.54 [95%CI: 0.11, 1.57] for breast cancer. \u0000Conclusion: Despite similarities to subpopulations with increased breast and overall cancer prevalence, the subpopulation of female plastic surgeons had no evdience of excess cancers compared to age and race-adjusted women in the general US population.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79385277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-03-25DOI: 10.4172/2167-0420.1000231
V. Vellanki, Sajana Gogineni, Jahnavi, S. Kanakamedala
Abstract Uterocutaneous fistula, although not exceptional, is a very rare clinical entity. It occurs most often after uterine or pelvic surgery. We report a case of Uterocutaneous fistula which was formed following lower segment caesarean section. MRI was helpful in the diagnosis and was treated successfully with hysterectomy. This report aims to remind practicing clinicians about this rare complication of caesarean section and discuss our experience with its management.
{"title":"Case Report of Uterocutaneous Fistula","authors":"V. Vellanki, Sajana Gogineni, Jahnavi, S. Kanakamedala","doi":"10.4172/2167-0420.1000231","DOIUrl":"https://doi.org/10.4172/2167-0420.1000231","url":null,"abstract":"Abstract \u0000Uterocutaneous fistula, although not exceptional, is a very rare clinical entity. It occurs most often after uterine or pelvic surgery. We report a case of Uterocutaneous fistula which was formed following lower segment caesarean section. MRI was helpful in the diagnosis and was treated successfully with hysterectomy. This report aims to remind practicing clinicians about this rare complication of caesarean section and discuss our experience with its management.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74947438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-03-01Epub Date: 2015-02-25DOI: 10.4172/2167-0420.1000225
Annamaria Masucci Twarozek, Thomas Eggert, Zachary G Puca, Nefertiti DuPont, Deborah O Erwin, Chester H Fox, Martin C Mahoney
Objective: This report assesses the impact of a series of education sessions delivered to office staff on the delivery of smoking cessation services among patients seeking care at a community-based women's health center.
Methods: A quasi-experimental design was used to examine the delivery of smoking cessation services to patients in a medical office before and after office staff attended a series of 3 educational sessions intended to increase their knowledge and self-efficacy to address cessation. Delivery of smoking cessation services was documented through a systematic review of medical records using a structured abstraction form.
Results: While nearly all smokers (93%) were asked about smoking status at their last office visit, few smokers at baseline or follow-up were assessed for interest in setting a quit date or offered pharmacotherapy. Referrals to the smokers quit line increased from <1% at baseline to 8% at follow-up (p<0.001) and "any assistance" also showed a modest but significant increase (<1% baseline, 9% follow-up, p<0.001).
Conclusion: This evaluation failed to identify clinical meaningful changes in the delivery of smoking cessation services in this women's health office before and after completion of a series of educational interventions for office staff. It is anticipated that the implementation of patient centered medical homes, and EMR systems, will help to enhance the delivery of smoking cessation services to women seeking medical care.
{"title":"Promoting Tobacco Cessation in a Community-Based Women's Health Centre.","authors":"Annamaria Masucci Twarozek, Thomas Eggert, Zachary G Puca, Nefertiti DuPont, Deborah O Erwin, Chester H Fox, Martin C Mahoney","doi":"10.4172/2167-0420.1000225","DOIUrl":"https://doi.org/10.4172/2167-0420.1000225","url":null,"abstract":"<p><strong>Objective: </strong>This report assesses the impact of a series of education sessions delivered to office staff on the delivery of smoking cessation services among patients seeking care at a community-based women's health center.</p><p><strong>Methods: </strong>A quasi-experimental design was used to examine the delivery of smoking cessation services to patients in a medical office before and after office staff attended a series of 3 educational sessions intended to increase their knowledge and self-efficacy to address cessation. Delivery of smoking cessation services was documented through a systematic review of medical records using a structured abstraction form.</p><p><strong>Results: </strong>While nearly all smokers (93%) were asked about smoking status at their last office visit, few smokers at baseline or follow-up were assessed for interest in setting a quit date or offered pharmacotherapy. Referrals to the smokers quit line increased from <1% at baseline to 8% at follow-up (p<0.001) and \"any assistance\" also showed a modest but significant increase (<1% baseline, 9% follow-up, p<0.001).</p><p><strong>Conclusion: </strong>This evaluation failed to identify clinical meaningful changes in the delivery of smoking cessation services in this women's health office before and after completion of a series of educational interventions for office staff. It is anticipated that the implementation of patient centered medical homes, and EMR systems, will help to enhance the delivery of smoking cessation services to women seeking medical care.</p>","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2167-0420.1000225","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34344434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-02-25DOI: 10.4172/2167-0420.1000226
B. Hoffman-Ruddy, Sarah Miller, E. Silverman, Lewis, H. Ho
Summary Squamous cell cancer of the head and neck (HNSCC) is an evolving area of clinical and research focus with a rising prevalence of the disease in the female population. Some human papillomavirus (HPV) types act as carcinogens that contribute to the development of HNSCC. The purpose of this article is to discuss the role of HPV in the rise of HNSCC in women, with a focus on shifting clinical practice guidelines.
{"title":"The Contagious Head and Neck Cancer: The Role of Human PapillomavirusHPV","authors":"B. Hoffman-Ruddy, Sarah Miller, E. Silverman, Lewis, H. Ho","doi":"10.4172/2167-0420.1000226","DOIUrl":"https://doi.org/10.4172/2167-0420.1000226","url":null,"abstract":"Summary Squamous cell cancer of the head and neck (HNSCC) is an evolving area of clinical and research focus with a rising prevalence of the disease in the female population. Some human papillomavirus (HPV) types act as carcinogens that contribute to the development of HNSCC. The purpose of this article is to discuss the role of HPV in the rise of HNSCC in women, with a focus on shifting clinical practice guidelines.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84071184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-02-25DOI: 10.4172/2167-0420.1000227
K. Yassin, Elfil Amh, H. Hamid, S. Ak, A. AziemAAli
Data was collected prospectively during the period of May 2011-through December 2012 at Khartoum Teaching Hospital from 75 pregnant women with heart diseases to investigate the epidemiology of cardiac disease in pregnancy. Means and proportions were calculated using student and X2 test, respectively. Univariate and multivariate analyses were performed, confidence intervals of 95% were calculated and P<0.05 was considered significant. With regard to classification of the cardiac disease, 60%, 26.7% and 13.3% was rheumatic heart disease, congenital heart disease and other acquired heart disease respectively. Ten cases were ended with therapeutic and spontaneous miscarriage and 65 cases reached viability. The reported medical problems that complicated the pregnancy of our patients included: congestive heart failure (14/75, 18.6%), arrhythmias (6/75, 8%), pulmonary embolism (4/75, 5.3%) and pulmonary oedema (2/75, 2.6%). There were two cases of maternal mortality (2.7%). In this study maternal cardiac complication were more common among women with past medical history of cardiac complication (OR=1.0; CI=, 1.0-1.0; P =0.023), NYHA class III & IV at booking (OR=15.9; CI=, 2.8-38; P =0.000), mitral stenosis without other valvular lesion (OR=5.3; CI=, 1.0-25.1; P =0.021), cardiomyopathy (OR=10; CI=, 1.1-88.6; P =0.036) and those without preconception counselling (OR=2.4; CI=, 1.3-4.2; P =0.002). Cardiac surgery prior to pregnancy did not guarantee a complication-free course in subsequent pregnancies. Thus Rheumatic heart disease is the most dominant aetiology of heart disease during pregnancy in Sudan. Cardiac surgery prior to pregnancy is not a grantee for pregnancy free complication.
{"title":"Epidemiology of Cardiac Disease during Pregnancy in Khartoum Hospital,Sudan","authors":"K. Yassin, Elfil Amh, H. Hamid, S. Ak, A. AziemAAli","doi":"10.4172/2167-0420.1000227","DOIUrl":"https://doi.org/10.4172/2167-0420.1000227","url":null,"abstract":"Data was collected prospectively during the period of May 2011-through December 2012 at Khartoum Teaching Hospital from 75 pregnant women with heart diseases to investigate the epidemiology of cardiac disease in pregnancy. Means and proportions were calculated using student and X2 test, respectively. Univariate and multivariate analyses were performed, confidence intervals of 95% were calculated and P<0.05 was considered significant. With regard to classification of the cardiac disease, 60%, 26.7% and 13.3% was rheumatic heart disease, congenital heart disease and other acquired heart disease respectively. \u0000Ten cases were ended with therapeutic and spontaneous miscarriage and 65 cases reached viability. The reported medical problems that complicated the pregnancy of our patients included: congestive heart failure (14/75, 18.6%), arrhythmias (6/75, 8%), pulmonary embolism (4/75, 5.3%) and pulmonary oedema (2/75, 2.6%). There were two cases of maternal mortality (2.7%). In this study maternal cardiac complication were more common among women with past medical history of cardiac complication (OR=1.0; CI=, 1.0-1.0; P =0.023), NYHA class III & IV at booking (OR=15.9; CI=, 2.8-38; P =0.000), mitral stenosis without other valvular lesion (OR=5.3; CI=, 1.0-25.1; P =0.021), cardiomyopathy (OR=10; CI=, 1.1-88.6; P =0.036) and those without preconception counselling (OR=2.4; CI=, 1.3-4.2; P =0.002). \u0000Cardiac surgery prior to pregnancy did not guarantee a complication-free course in subsequent pregnancies. Thus Rheumatic heart disease is the most dominant aetiology of heart disease during pregnancy in Sudan. Cardiac surgery prior to pregnancy is not a grantee for pregnancy free complication.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90234078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-31DOI: 10.4172/2167-0420.1000223
Emily C. Dossett, Erica Z. Shoemaker, Sarah E. Nasatir-Hilty, J. Daly, D. Hilty
“Integrated” behavioral health care most often refers to coordinated primary care and mental health care delivery at a co-located clinical site or psychiatric consultation service to a primary care clinical site. Women’s perinatal medical and mental health is an ideal target for integrated, patient-centered, and family-centered care. A three pronged approach is proposed to: 1) identify solutions for current barriers to mental health care delivery for pre- and postpartum women, 2) understand the relevance, steps toward and other thematic “how to” aspects of improving access to perinatal mental health services for the ongoing health of both mother and child, and 3) learn specifics of addressing maternal mental health, infant dyadic therapy, and enhanced parenting support. It borrows from the areas of stepped care, interdisciplinary teamwork, specific matching of treatments to disorders and stages of illness, and a range of individual, dyad, family and group treatments. These treatments are accessible, reduce stigmatization, and appropriate for dissemination using technology.
{"title":"Integrated Care for Women, Mothers, Children and Newborns: Approaches and Models for Mental Health, Pediatric and Prenatal Care Settings","authors":"Emily C. Dossett, Erica Z. Shoemaker, Sarah E. Nasatir-Hilty, J. Daly, D. Hilty","doi":"10.4172/2167-0420.1000223","DOIUrl":"https://doi.org/10.4172/2167-0420.1000223","url":null,"abstract":"“Integrated” behavioral health care most often refers to coordinated primary care and mental health care delivery at a co-located clinical site or psychiatric consultation service to a primary care clinical site. Women’s perinatal medical and mental health is an ideal target for integrated, patient-centered, and family-centered care. A three pronged approach is proposed to: 1) identify solutions for current barriers to mental health care delivery for pre- and postpartum women, 2) understand the relevance, steps toward and other thematic “how to” aspects of improving access to perinatal mental health services for the ongoing health of both mother and child, and 3) learn specifics of addressing maternal mental health, infant dyadic therapy, and enhanced parenting support. It borrows from the areas of stepped care, interdisciplinary teamwork, specific matching of treatments to disorders and stages of illness, and a range of individual, dyad, family and group treatments. These treatments are accessible, reduce stigmatization, and appropriate for dissemination using technology.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87089327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-23DOI: 10.4172/2167-0420.1000213
Gavin R. Armstrong, A. Summerlee
The current review identifies the root causes of the problem, assesses the clinical impact of iron deficiency and iron deficiency anemia with a specific focus on the condition in developing countries, and outlines the potential solutions to address the problem. Iron deficiency, the most common micronutrient deficiency in the world, results from an imbalance in the access and use of iron in the body. Although it is found in the developing and developed world, it predominantly affects women and children especially those living in poverty. The clinical effects of iron deficiency are profound: mild deficiency results in the loss of concentration in children – affecting their performance at school, and reduces work capacity in adults – affecting their ability to work a full week of work; more profound effects can seriously and permanently damage cognitive development and pose serious health issues in pregnancy and child birth. Despite substantial international efforts to address iron deficiency, the levels have continued to rise over the last decade. As we have the technology to solve this problem, the Copenhagen Consensus Centre (which meets every four years) has identified iron deficiency as the principal health challenge facing the world: the health and economic burden falling predominantly on women of reproductive age.
{"title":"The Etiology, Treatment and Effective Prevention of Iron Deficiency and Iron Deficiency Anemia in Women and Young Children Worldwide: A Review","authors":"Gavin R. Armstrong, A. Summerlee","doi":"10.4172/2167-0420.1000213","DOIUrl":"https://doi.org/10.4172/2167-0420.1000213","url":null,"abstract":"The current review identifies the root causes of the problem, assesses the clinical impact of iron deficiency and iron deficiency anemia with a specific focus on the condition in developing countries, and outlines the potential solutions to address the problem. Iron deficiency, the most common micronutrient deficiency in the world, results from an imbalance in the access and use of iron in the body. Although it is found in the developing and developed world, it predominantly affects women and children especially those living in poverty. The clinical effects of iron deficiency are profound: mild deficiency results in the loss of concentration in children – affecting their performance at school, and reduces work capacity in adults – affecting their ability to work a full week of work; more profound effects can seriously and permanently damage cognitive development and pose serious health issues in pregnancy and child birth. Despite substantial international efforts to address iron deficiency, the levels have continued to rise over the last decade. As we have the technology to solve this problem, the Copenhagen Consensus Centre (which meets every four years) has identified iron deficiency as the principal health challenge facing the world: the health and economic burden falling predominantly on women of reproductive age.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84617872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-10DOI: 10.4172/2167-0420.1000220
Nida Hameed, H. Tatari, A. Shibli, H. Narchi
We aimed to study the maternal factors that may hinder successful breastfeeding in a prospective cohort study of a cohort of 269 mother-child pairs (under two years of age) who presented over a 3-month period to a primary healthcare facility in Al Ain city, United Arab Emirates. Explanatory data was collected from the mothers by a face-to-face questionnaire survey. The mean age of the children at enrolment was 7 months (median 6, range 1 to 24). Ninety-six infants (36%) had been exclusively breastfed, 31 (11.5%) exclusively formula fed while 142 (52.8%) had received mixed feeding. Exclusive breastfeeding was significantly less common (n=29, 30.2%) among employed women (p=0.008) compared to those exclusively formula fed (n=17, 54.8%) or mixed fed (n=68, 47.9%). There was a significant (p<0.05) downward trend in the proportion of exclusively breastfed and of mixed fed infants between firstborn infants (n=44, 45.8%) and their subsequent siblings (n=81, 57%). In the city of Al Ain, the main factors impeding breastfeeding were mothers’ employment and their lack of awareness of the benefits of breastfeeding. Enhancing the health education of the mothers is urgently needed.
{"title":"Maternal Factors Hindering Successful Breastfeeding in Al Ain City, United Arab Emirates","authors":"Nida Hameed, H. Tatari, A. Shibli, H. Narchi","doi":"10.4172/2167-0420.1000220","DOIUrl":"https://doi.org/10.4172/2167-0420.1000220","url":null,"abstract":"We aimed to study the maternal factors that may hinder successful breastfeeding in a prospective cohort study of a cohort of 269 mother-child pairs (under two years of age) who presented over a 3-month period to a primary healthcare facility in Al Ain city, United Arab Emirates. Explanatory data was collected from the mothers by a face-to-face questionnaire survey. The mean age of the children at enrolment was 7 months (median 6, range 1 to 24). Ninety-six infants (36%) had been exclusively breastfed, 31 (11.5%) exclusively formula fed while 142 (52.8%) had received mixed feeding. Exclusive breastfeeding was significantly less common (n=29, 30.2%) among employed women (p=0.008) compared to those exclusively formula fed (n=17, 54.8%) or mixed fed (n=68, 47.9%). There was a significant (p<0.05) downward trend in the proportion of exclusively breastfed and of mixed fed infants between firstborn infants (n=44, 45.8%) and their subsequent siblings (n=81, 57%). In the city of Al Ain, the main factors impeding breastfeeding were mothers’ employment and their lack of awareness of the benefits of breastfeeding. Enhancing the health education of the mothers is urgently needed.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88697707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-09DOI: 10.4172/2167-0420.1000222
S. Morino, M. Ishihara, S. Nishiguchi, N. Fukutani, Daiki Adachi, Y. Tashiro, T. Hotta, M. Yamada, M. Yamashita, T. Aoyama
Objective: To determine the association between pregnancy-related discomforts and pre-pregnancy body mass index in a longitudinal study. Methods: The study included 355 pregnant women (age, 31.1 ± 4.1 years). Participants were divided into three groups according to their pre-pregnancy body mass index: the low body mass index group, normal body mass index group, and high body mass index group. The occurrence of pregnancy-related discomforts during the second and third trimesters was investigated. Binomial logistic regression analysis was used to examine the association between pre-pregnancy body mass index and pregnancy-related discomforts experienced during the last two trimesters. Results: The occurrence of most pregnancy-related discomforts increased in the third trimester, while that of constipation and shoulder stiffness or headache decreased. Based on logistic regression analysis, pre-pregnancy body mass index was significantly associated with various discomforts. The occurrence of hip joint or pubis pain (odds ratio/95% confidence interval = 2.38/1.14–4.95) during the second trimester, and sleeping difficulty (2.00/1.09–3.67), hand or finger stiffness (3.00/1.36–6.45), leg cramps (2.29/1.32–3.98), low back pain (2.20/1.29– 3.75), hip joint or pubis pain (2.14/1.23–3.73), and shoulder stiffness or headache (2.01/1.06–3.82) during the third trimester was significantly higher in the high body mass index group than in the normal body mass index group. The low body mass index group exhibited a significantly a higher occurrence of shoulder stiffness or headache (2.84/1.35–5.96) during the second trimester and constipation (2.28/1.08–4.82) during the third trimester than the normal body mass index group. Conclusion: The occurrence of discomforts decreased or increased during pregnancy. Furthermore, both prepregnancy high and low body mass index represent important risk factors for many pregnancy-related discomforts, compared with a pre-pregnancy normal body mass index.
{"title":"The Association between Pregnancy-Related Discomforts and Pre-Pregnancy Body Mass Index in Japanese Women","authors":"S. Morino, M. Ishihara, S. Nishiguchi, N. Fukutani, Daiki Adachi, Y. Tashiro, T. Hotta, M. Yamada, M. Yamashita, T. Aoyama","doi":"10.4172/2167-0420.1000222","DOIUrl":"https://doi.org/10.4172/2167-0420.1000222","url":null,"abstract":"Objective: To determine the association between pregnancy-related discomforts and pre-pregnancy body mass index in a longitudinal study. \u0000Methods: The study included 355 pregnant women (age, 31.1 ± 4.1 years). Participants were divided into three groups according to their pre-pregnancy body mass index: the low body mass index group, normal body mass index group, and high body mass index group. The occurrence of pregnancy-related discomforts during the second and third trimesters was investigated. Binomial logistic regression analysis was used to examine the association between pre-pregnancy body mass index and pregnancy-related discomforts experienced during the last two trimesters. \u0000Results: The occurrence of most pregnancy-related discomforts increased in the third trimester, while that of constipation and shoulder stiffness or headache decreased. Based on logistic regression analysis, pre-pregnancy body mass index was significantly associated with various discomforts. The occurrence of hip joint or pubis pain (odds ratio/95% confidence interval = 2.38/1.14–4.95) during the second trimester, and sleeping difficulty (2.00/1.09–3.67), hand or finger stiffness (3.00/1.36–6.45), leg cramps (2.29/1.32–3.98), low back pain (2.20/1.29– 3.75), hip joint or pubis pain (2.14/1.23–3.73), and shoulder stiffness or headache (2.01/1.06–3.82) during the third trimester was significantly higher in the high body mass index group than in the normal body mass index group. The low body mass index group exhibited a significantly a higher occurrence of shoulder stiffness or headache (2.84/1.35–5.96) during the second trimester and constipation (2.28/1.08–4.82) during the third trimester than the normal body mass index group. \u0000Conclusion: The occurrence of discomforts decreased or increased during pregnancy. Furthermore, both prepregnancy high and low body mass index represent important risk factors for many pregnancy-related discomforts, compared with a pre-pregnancy normal body mass index.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88066107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2015-01-03DOI: 10.4172/2167-0420.1000215
M. Hummeida, R. Salah, I. Hussien, G. Adam, A. Ali
Although the potential benefit of Tamoxifen treatment in breast cancer patients outweighs its risk; however, all patients receiving Tamoxifen should undergo regular gynecologic evaluations. To survey the endometrial abnormality (endometrial thicknesses of 8 mm and more) using Trans-vaginal Ultrasound (TVS), data was collected prospectively from 104 patients with histologically confirmed stage I or II breast carcinoma, on Tamoxifen therapy for at least 6 months duration at Radiation and Isotopes Centre in Khartoum (RICK), Sudan during the period of June 2013 through December 2013. Means and proportions were compared between those with normal and abnormal endometrial thickness using student and chi-square test, respectively. P < 0.05 was considered significant. The mean (SD) duration of Tamoxifen use was 22 months. Among the total patients 39 (37.5%), 29 (27.8%), 20 (19.3%) and 16 (15.4%) used Tamoxifen for < 24, 24-36, 36-48 and ≥ 48 months respectively. Normal TVS was observed in 45 patients and abnormal findings were reported in 59 patients. In this study abnormal endometrial thickness was noticed more among nulliparous (p ≤ 0.001), longer duration of Tamoxifen use (p ≤ 0.001), premenopausal status (p ≤ 0.001), smoking (p ≤ 0.024) and BMI (p ≤ 0.001). In Conclusion: Although the discussions about endometrial screening in patients receiving Tamoxifen are still controversial, our study revealed strong association between Tamoxifen therapy and endometrial abnormality.
{"title":"Ultrasonographic Appearance of the Uterine Endometrium in Sudanese Breast Cancer Women on Tamoxifen Therapy","authors":"M. Hummeida, R. Salah, I. Hussien, G. Adam, A. Ali","doi":"10.4172/2167-0420.1000215","DOIUrl":"https://doi.org/10.4172/2167-0420.1000215","url":null,"abstract":"Although the potential benefit of Tamoxifen treatment in breast cancer patients outweighs its risk; however, all patients receiving Tamoxifen should undergo regular gynecologic evaluations. To survey the endometrial abnormality (endometrial thicknesses of 8 mm and more) using Trans-vaginal Ultrasound (TVS), data was collected prospectively from 104 patients with histologically confirmed stage I or II breast carcinoma, on Tamoxifen therapy for at least 6 months duration at Radiation and Isotopes Centre in Khartoum (RICK), Sudan during the period of June 2013 through December 2013. Means and proportions were compared between those with normal and abnormal endometrial thickness using student and chi-square test, respectively. P < 0.05 was considered significant. The mean (SD) duration of Tamoxifen use was 22 months. Among the total patients 39 (37.5%), 29 (27.8%), 20 (19.3%) and 16 (15.4%) used Tamoxifen for < 24, 24-36, 36-48 and ≥ 48 months respectively. Normal TVS was observed in 45 patients and abnormal findings were reported in 59 patients. In this study abnormal endometrial thickness was noticed more among nulliparous (p ≤ 0.001), longer duration of Tamoxifen use (p ≤ 0.001), premenopausal status (p ≤ 0.001), smoking (p ≤ 0.024) and BMI (p ≤ 0.001). In \u0000Conclusion: Although the discussions about endometrial screening in patients receiving Tamoxifen are still controversial, our study revealed strong association between Tamoxifen therapy and endometrial abnormality.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90895996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：